These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 93875)

  • 1. Degradation of myelin basic protein by cerebrospinal fluid: preservation of antigenic determinants under physiological conditions.
    Alvord EC; Hruby S; Sires LR
    Ann Neurol; 1979 Dec; 6(6):474-82. PubMed ID: 93875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelin basic protein and its free and bound antibodies in cerebrospinal fluid. All three must be determined on each specimen.
    Alvord EC; Hruby S
    Acta Neurol (Napoli); 1991 Apr; 13(2):97-106. PubMed ID: 1716403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitopes of immunoreactive myelin basic protein in human cerebrospinal fluid.
    Whitaker JN; Gupta M; Smith OF
    Ann Neurol; 1986 Sep; 20(3):329-36. PubMed ID: 2429613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders.
    Whitaker JN; Lisak RP; Bashir RM; Fitch OH; Seyer JM; Krance R; Lawrence JA; Ch'ien LT; O'Sullivan P
    Ann Neurol; 1980 Jan; 7(1):58-64. PubMed ID: 6153879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antigenic reactivity of small fragments derived from human myelin basic protein peptide 43-88.
    Whitaker JN
    J Immunol; 1982 Dec; 129(6):2729-33. PubMed ID: 6183342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular features of immunoreactive myelin basic protein in cerebrospinal fluid of persons with multiple slcerosis.
    Bashir RM; Whitaker JN
    Ann Neurol; 1980 Jan; 7(1):50-7. PubMed ID: 6153878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of immunoreactive myelin basic protein peptide (45-89) in cerebrospinal fluid.
    Gupta MK; Whitaker JN; Johnson C; Goren H
    Ann Neurol; 1988 Mar; 23(3):274-80. PubMed ID: 2454068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of myelin basic protein in cerebrospinal fluid.
    Ohta M; Ohta K
    Expert Rev Mol Diagn; 2002 Nov; 2(6):627-33. PubMed ID: 12465458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactive myelin basic protein in the cerebrospinal fluid in neurological disorders.
    Whitaker JN; Lisak RP; Bashir RM; Krance R; Lawrence JA; Ch'ien LT; O'Sullivan P
    Trans Am Neurol Assoc; 1978; 103():212-5. PubMed ID: 92844
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnostic value of cerebrospinal fluid myelin basic protein in patients with neurological illness.
    Davies L; McLeod JG; Muir A; Hensley WJ
    Clin Exp Neurol; 1987; 24():5-10. PubMed ID: 2478320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of myelin breakdown in demyelinating diseases: role of proteolytic enzymes.
    Banik NL
    Crit Rev Neurobiol; 1992; 6(4):257-71. PubMed ID: 1384994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myelin basic protein and its antibodies in the cerebrospinal fluid in experimental allergic encephalomyelitis, multiple sclerosis and other diseases.
    Alvord EC; Hruby S; Shaw CM; Slimp J
    Prog Clin Biol Res; 1984; 146():359-63. PubMed ID: 6201907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis.
    Cuzner ML; Davison AN; Rudge P
    Ann Neurol; 1978 Oct; 4(4):337-44. PubMed ID: 83119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Determination of myelin basic protein in the cerebrospinal fluid in neurologic diseases].
    Bürgisser P; Matthieu JM; de Tribolet N; Gautier E
    Schweiz Med Wochenschr; 1982 May; 112(18):643-7. PubMed ID: 6177033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of immunoreactive myelin basic protein peptide in urine of persons with multiple sclerosis.
    Whitaker JN
    Ann Neurol; 1987 Nov; 22(5):648-55. PubMed ID: 2447826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of primary antibodies of the myelin basic protein antibody cascade from multiple sclerosis patients. Immunoreactivity studies with homologous and heterologous antigens.
    Warren KG; Catz I
    Clin Invest Med; 1992 Feb; 15(1):18-29. PubMed ID: 1373999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoreactive myelin basic protein in cerebrospinal fluid of patients with peripheral neuropathies.
    Cornblath DR; Griffin JW; Tennekoon GI
    Ann Neurol; 1986 Sep; 20(3):370-2. PubMed ID: 2429614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid-induced recognition of a conformational determinant (residues 65 to 83) in myelin basic protein.
    Boggs JM; Hashim GA; Day ED; Moscarello MA
    J Immunol; 1985 Oct; 135(4):2617-22. PubMed ID: 2411805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune encephalomyelitis (EAE) mediated or prevented by T lymphocyte lines directed against diverse antigenic determinants of myelin basic protein. Vaccination is determinant specific.
    Holoshitz J; Frenkel A; Ben-Nun A; Cohen IR
    J Immunol; 1983 Dec; 131(6):2810-3. PubMed ID: 6196400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fasciola hepatica: parasite-secreted proteinases degrade all human IgG subclasses: determination of the specific cleavage sites and identification of the immunoglobulin fragments produced.
    Berasain P; Carmona C; Frangione B; Dalton JP; Goñi F
    Exp Parasitol; 2000 Feb; 94(2):99-110. PubMed ID: 10673346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.